Search Results - "Dutoit, V"

Human tissue engineering allows the identification of active miRNA regulators of glioblastoma aggressiveness by Cosset, E, Petty, T, Dutoit, V, Tirefort, D, Otten-Hernandez, P, Farinelli, L, Dietrich, P.-Y, Preynat-Seauve, O

“…Abstract Glioblastoma multiforme (GBM) is among the most aggressive cancers associated with massive infiltration of peritumoral parenchyma by migrating tumor…”
Get full text

Ipilimumab-related hypophysitis may precede severe CNS immune attack by Köessler, T., Olivier, T., Fertani, S., Marinari, E., Dutoit, V., Dietrich, P.-Y.

“…Reintroduction of ipilimumab after recovery or hormonal substitution for hypophysitis should be carefully done especially in the presence of minor neurological…”
Get full text

Glut3 addiction is a druggable vulnerability for a molecularly defined subpopulation of glioblastoma by Cosset, É, Ilmjärv, S., Dutoit, V., Elliott, K., von Schalscha, T., Reiss, A., Camargo, M.F., Moroishi, T., Seguin, L., Gomez, G., Moo, J.S., Preynat-Seauve, O., Krause, K.H., Chneiweiss, H., Guan, K.L., Dietrich, P.Y., Weis, S.M., Mischel, P.S., Cheresh, D.A.

Get full text

Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases by Dubucquoi, S, Solau-Gervais, E, Lefranc, D, Marguerie, L, Sibilia, J, Goetz, J, Dutoit, V, Fauchais, A-L, Hachulla, E, Flipo, R-M, Prin, L

“…Background: Anti-filaggrin antibodies (AFA) are among the most specific antibodies for rheumatoid arthritis, so procedures for their detection should be…”
Get full text

IgG reactivity against citrullinated myelin basic protein in multiple sclerosis by de Seze, J., Dubucquoi, S., Lefranc, D., Virecoulon, F., Nuez, I., Dutoit, V., Vermersch, P., Prin, L.

“…An increased level of citrullinated myelin basic protein (MBP-C8) has been reported in the brains of multiple sclerosis (MS) patients. However, the involvement…”
Get full text

Efficient Simultaneous Presentation of NY-ESO-1/LAGE-1 Primary and Nonprimary Open Reading Frame-Derived CTL Epitopes in Melanoma by Rimoldi, Donata, Rubio-Godoy, Verena, Dutoit, Valerie, Lienard, Danielle, Salvi, Suzanne, Guillaume, Philippe, Speiser, Daniel, Stockert, Elisabeth, Spagnoli, Giulio, Servis, Catherine, Cerottini, Jean-Charles, Lejeune, Ferdy, Romero, Pedro, Valmori, Danila

“…Recent studies have shown that CTL epitopes derived from tumor-associated Ags can be encoded by both primary and nonprimary open reading frames (ORF). In this…”
Get full text

Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study by Gonvers, Jean-Jacques, Heim, Markus H, Cavassini, Matthias, Müllhaupt, Beat, Genné, Daniel, Bernasconi, Enos, Borovicka, Jan, Cerny, Andreas, Chave, Jean-Philippe, Chuard, Christian, Dufour, François, Dutoit, Valérie, Malinverni, Raffaelle, Monnat, Martine, Negro, Francesco, Troilliet, Nicolas, Oneta, Carl

“…Treatment of chronic HCV infection has become a priority in HIV+ patients, given the faster progression to end-stage liver disease. The primary endpoint of…”
Get full text

53P A multispecific non-integrating RNA CAR T platform to overcome the clinical challenge of glioblastoma heterogeneity by Martínez Bedoya, D., Gustave, R., Corlazzoli, F., Dutoit, V., Migliorini, D.

Get full text

59P Oncolytic adenovirus-based therapeutics to target or reprogram glioma-associated macrophages by de Sostoa, J., Marinari, E., Widmer, V., Iwaszkiewicz, J., Zoete, V., Michielin, O., Dutoit, V., Migliorini, D.

Get full text

234P Oncolytic adenovirus-based therapeutics to reprogram the glioblastoma microenvironment for improved CAR T cell therapy by de Sostoa Pomés, J., Widmer, V., Dutoit, V., Migliorini, D.M.

Get full text

Interferon beta in multiple sclerosis: relationship between sustained serum IgG levels and clinical outcome by Dubucquoi, S, de Seze, J, Lefranc, D, Almeras, L, Dutoit, V, Prin, L, Vermersch, P

“…We investigated the effects of interferon beta-1a (IFN β-1a) on specific response towards two immunodominant MBP peptides and on global production of IgG. We…”
Get full text

P-115 PEMREC: A phase II study to evaluate safety and efficacy of neo-adjuvant pembrolizumab and radiotherapy in localized microsatellite stable rectal cancer by Kössler, T., Buchs, N., Dutoit, V., Puppa, G., Tsantoulis, P., Frossard, J., Bichard, P., McKee, T., Di Marco, M., Dietrich, P., Roth, A., Zilli, T., Ris, F.

Get full text

IMA950 multipeptide vaccine adjuvanted with poly-ICLC in combination with standard therapy in newly diagnosed HLA-A2 glioblastoma patients by Dutoit, V., Migliorini, D., Patrikidou, A., Mayer-Mokler, A., Hilf, N., Walker, P.R., Dietrich, P-Y

Get full text

Phase I/II study of IMA950 peptide vaccine with Poly-ICLC in combination with standard therapy in newly diagnosed A2 glioblastoma: Preliminary results by Migliorini, D., Dutoit, V., Walker, P.R., Dietrich, P.-Y.

Get full text

Development of chimeric antigen receptor (CAR) T cells for immunotherapy of glioma by Dutoit, V., Chaitanya, K., Walker, P.R., Dietrich, P.-Y.

Get full text

P01.122 Safety, immunogenicity and optimization of the IMA950 multipeptide vaccine combined with Poly-ICLC in newly diagnosed HLA-A2 malignant glioma patients by Migliorini, D, Dutoit, V, Allard, M, Mohan, S, Lobrinus, A, Merkler, D, Vargas, M, Walker, P R, Patrikidou, A, Dietrich, P

“…Abstract Background The clinical development of immunotherapy is still limited for patients with malignant glioma. We report the results of a phase I/II study…”
Get full text

Fecal microbiota transplantation from patients with pancreatic cancer into germ-free mice: metataxonomic and metabolic impact by Djaafar, S., Schrenzel, J., Stojanovic, O., Koessler, T., Herrmann, F., Lazarevic, V., Gaia, N., Mareschal, J., MacPherson, A., Spiljar, M., Dutoit, V., Trajkovski, M., Genton Graf, L.

Get full text

Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients by VALMORI, D, DUTOIT, V, CEROTTINI, J.-C, ROMERO, P, LIENARD, D, RIMOLDI, D, PITTET, M. J, CHAMPAGNE, P, ELLEFSEN, K, SAHIN, U, SPEISER, D, LEJEUNE, F

“…Cancer testis (CT) antigens are particularly interesting candidates for cancer vaccines. However, T-cell reactivity to CT antigens has been detected only…”
Get full text

Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma by Romero, Pedro, Valmori, Danila, Pittet, Mikael J., Zippelius, Alfred, Rimoldi, Donata, Lévy, Frederic, Dutoit, Valérie, Ayyoub, Maha, Rubio-Godoy, Verena, Michielin, Olivier, Guillaume, Philippe, Batard, Pascal, Luescher, Immanuel F., Lejeune, Ferdy, Liénard, Danielle, Rufer, Nathalie, Dietrich, Pierre-Yves, Speiser, Daniel E., Cerottini, Jean-Charles

“…Some cancer patients mount spontaneous T‐ and B‐cell responses against their tumor cells. Autologous tumor reactive CD8 cytolytic T lymphocyte (CTL) and CD4…”
Get full text

Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activity by Dutoit, V, Rubio-Godoy, V, Dietrich, P Y, Quiqueres, A L, Schnuriger, V, Rimoldi, D, Liénard, D, Speiser, D, Guillaume, P, Batard, P, Cerottini, J C, Romero, P, Valmori, D

“…MAGE-encoded antigens, which are expressed by tumors of many histological types but not in normal tissues, are suitable candidates for vaccine-based…”
Get full text